Affiliation:
1. Department of Internal Medicine, Karaganda Medical University, Karaganda 100000, Kazakhstan
Abstract
(1) Background: Endothelial dysfunction is a key mechanism in the pathogenesis of COVID-19. High endothelin-1 during COVID-19 is associated with severe complications and increased mortality rates during hospitalization. This study is aimed to investigate the association of endothelin-1 levels with the risk of 30-day and 12-month all-cause mortality in patients with prior COVID-19. (2) Methods: A prospective study was conducted involving patients with COVID-19 in Karaganda, Kazakhstan. The level of endothelin-1 in the blood serum was evaluated by ELISA. Univariate and multivariate Cox regression was used to determine factors and significance of endothelin-1 associated with the risk of mortality within 30 and 365 days from hospitalization. (3) Results: The median endothelin-1 was higher in the group of patients who passed away within 30 days. The group showed statistically significant differences when compared to healthy volunteers from the control group (p = 0.0001), surviving patients (p = 0.001), and those who passed away within a year (p = 0.002). (4) Conclusions: Endothelin-1 levels are associated with increased mortality risk during the acute period of COVID-19, while plasma endothelin-1 level association with COVID-19 survivor mortality risk does not persist after 12 months.
Funder
Ministry of Healthcare of the Republic of Kazakhstan
Reference43 articles.
1. (2023, May 05). WHO Director-General’s Opening Remarks at the Media Briefing. Available online: https://www.who.int/news-room/speeches/item/who-director-general-s-opening-remarks-at-the-media-briefing.
2. Predictors of Mortality Among Post-COVID-19 Discharged Patients in Northern India: A Case-Control Study;Kumar;Cureus,2023
3. Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System;Donnelly;JAMA,2021
4. High-Dimensional Characterization of Post-Acute Sequelae of COVID-19;Xie;Nature,2021
5. COVID-19 Post-Acute Sequelae Among Adults: 12 Month Mortality Risk;Mainous;Front. Med.,2021